US 11648247
Compositions and methods for the treatment of presbyopia
granted A61KA61K31/439A61K31/498
Quick answer
US patent 11648247 (Compositions and methods for the treatment of presbyopia) held by Lenz Therapeutics, Inc. expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Lenz Therapeutics, Inc.
- Grant date
- Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/439, A61K31/498, A61K47/02, A61K47/10